Pfizer Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Pfizer Inc. reported total assets of $208.16B and shareholders' equity of $86.48B. That works out to liabilities equal to 58% of assets, a current ratio of 1.16 (current assets ÷ current liabilities), long-term debt of 0.71× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $171.62B | $171.80B | $159.42B | $167.59B | $154.23B | $181.48B | $197.21B | $226.50B | $213.40B | $208.16B |
| Current assets | $38.95B | $41.14B | $49.93B | $32.80B | $35.07B | $59.69B | $51.26B | $43.33B | $50.36B | $42.90B |
| Cash & equivalents | $2.60B | $1.34B | $1.14B | $1.12B | $1.79B | $1.94B | $416.00M | $2.85B | $1.04B | $1.14B |
| Total liabilities | $111.78B | $100.14B | $95.66B | $104.15B | $90.76B | $104.01B | $101.29B | $137.21B | $124.90B | $121.39B |
| Current liabilities | $31.11B | $30.43B | $31.86B | $37.30B | $25.92B | $42.67B | $42.14B | $47.79B | $42.99B | $36.98B |
| Long-term debt | $31.40B | $33.54B | $32.91B | $35.95B | $37.13B | $36.20B | $32.88B | $61.54B | $57.41B | $61.64B |
| Shareholders' equity | $59.54B | $71.31B | $63.41B | $63.14B | $63.24B | $77.20B | $95.66B | $89.01B | $88.20B | $86.48B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 78003 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.